Tandem Diabetes Care
TNDM
290 hedge funds and large institutions have $5.08B invested in Tandem Diabetes Care in 2021 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 105 increasing their positions, 102 reducing their positions, and 59 closing their positions.
53% more call options, than puts
Call options by funds: $68M | Put options by funds: $44.5M
3% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 102
1.94% less ownership
Funds ownership: 94.01% → 92.07% (-1.9%)
6% less funds holding
Funds holding: 309 → 290 (-19)
9% less capital invested
Capital invested by funds: $5.59B → $5.08B (-$515M)
25% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 59
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$125M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$57.8M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$48.2M |
| 4 |
RI
RTW Investments
New York
|
+$44.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$41.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$160M |
| 2 |
FAM
Fred Alger Management
New York
|
-$107M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$56.6M |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$44.8M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$40.6M |
TNDM Hedge Fund Activity: Q1 2021 in Review
290 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2021, worth a combined $5.08B — down 9.2% from $5.59B a quarter earlier.
Sellers outnumbered buyers: 59 funds closed out of TNDM and 44 opened new positions — a net loss of 15 holders — while 102 trimmed existing stakes and 105 added.
The largest buyer was Champlain Investment Partners, opening a new position worth an estimated $125M. The largest seller was Wellington Management Group, cutting an estimated $160M.
- 290 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2021, down from 309 in Q4 2020.
- Funds reported $5.08B of Tandem Diabetes Care stock for Q1 2021, down 9.2% quarter-over-quarter.
- 44 funds opened new Tandem Diabetes Care positions in Q1 2021 and 59 closed out, a net change of -15 holders.
- The largest Tandem Diabetes Care buyer in Q1 2021 was Champlain Investment Partners, an estimated $125M added.
- The largest Tandem Diabetes Care seller in Q1 2021 was Wellington Management Group, an estimated $160M sold.
Based on aggregated 13F filings for Q1 2021.